ADHD
138 results
1 - 100
ADHD - Meditation therapies for ADHD
- Parent training interventions for ADHD
EEG inaccurate in diagnosing ADHD
Meditation therapies for attention‐deficit/hyperactivity disorder (ADHD) New- Bupropion for attention deficit hyperactivity disorder (ADHD) in adults New
- Social skills training for ADHD in children
- St. John's wort not effective for treatment of ADHD
- Screening tool for adult ADHD of uncertain effectiveness
- In-school neurofeedback improves ADHD symptom scores
- Guanfacine effective for ADHD but side effects are significant
- Immediate‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults New
- ADHD medications not associated with increased risk of CVD
- Polyunsaturated fatty acids (PUFA) for ADHD in children and adolescents
- Extended‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults New
- Drug treatment for ADHD in children with comorbid tic disorders
- Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents New
- Sleep counseling improves sleep and symptoms in children with ADHD
- A restriction diet will benefit some children with ADHD
- Cognitive-behavioural interventions for attention deficit hyperactivity disorder (ADHD) in adults: Cochrane systematic review
- Acupuncture for Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents: Cochrane systematic review
- Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents: Cochrane systematic review
- Cognitive‐behavioural interventions for attention deficit hyperactivity disorder (ADHD) in adults
- Digital media use associated with ADHD symptom development among adolescents
- Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults: Cochrane systematic review
- ADHD drugs do not increase serious CV events in children and young adults
- No increased risk of ASD, ADHD, or SGA with first-trimester antidepressant use
- Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents
- Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents: Cochrane systematic review
- Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults New search for studies and content updated (no change to conclusions)
- 2019 guidelines for ADHD: structure plus medication
- Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD) Edited (no change to conclusions), comment added to review
- Higher risk of psychosis with amphetamines than methylphenidate in treatment of ADHD
- Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years: Cochrane systematic review
- Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders New search for studies and content updated (no change to conclusions)
- Social skills training for attention deficit hyperactivity disorder (ADHD) in children aged 5 to 18 years New search for studies and content updated (no change to conclusions)
- Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents – assessment of adverse events in non-randomised studies: Cochrane systematic review
- Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents – assessment of adverse events in non‐randomised studies
- Risperidone for attention‐deficit hyperactivity disorder in people with intellectual disabilities Edited (no change to conclusions)
- Amfetamine for attention deficit hyperactivity disorder in people with intellectual disabilities Edited (no change to conclusions)
- Family therapy for attention‐deficit disorder or attention‐deficit/hyperactivity disorder in children and adolescents Edited (no change to conclusions)
- Dextroamphetamine for attention deficit hyperactivity disorder in children with intellectual disabilities
- Atomoxetine better than placebo but not uniformly effective in young children
- Treatments for attention-deficit/hyperactivity disorder
- Psychopharmacotherapy in children and adolescents